Miotic Pharmaceuticals

Miotic Pharmaceuticals is a biotechnology company focused on developing innovative ophthalmic treatments, specifically targeting age-related vision conditions. The company's primary focus is the development of a proprietary miotic formulation designed to treat presbyopia, a common condition characterized by the gradual loss of the eye's ability to focus on nearby objects. By utilizing small molecule muscarinic agonists, Miotic Pharmaceuticals aims to provide a non-invasive, pharmacological alternative to reading glasses or surgery. The company is currently advancing its lead candidate through pre-clinical stages to establish safety and efficacy for future clinical trials.